The information gathered in the course of the inspection shall be the subject of a report sent by the inspector in charge of the inspection to the Director General of the Agency. This report is sent to the person who was inspected. The person may make comments within fifteen days. In the light of the shortcomings noted in the inspection report and these observations, the Director General may decide to…
In agreement with the Director General of the Agence nationale de sécurité du médicament et des produits de santé, the Director General of the Agency may decide to carry out a joint inspection, in particular when this concerns an establishment or body carrying out activities on the same site which have been authorised by both of these agencies in application of the legislative and regulatory provisions in force.
The overall allocation provided for in article L. 1418-7 is set by order of the ministers responsible for health, social security and the budget. It is revised in the same way.
In addition to the global grant provided for in Article L. 1418-7, the Agency’s resources include : 1° Endowments, subsidies and other payments from public authorities and all national and international public and private bodies; 2° Proceeds from the shareholdings referred to in 12° of article R. 1418-13; 3° Remuneration for services rendered; 4° Proceeds from taxes and charges levied in its favour; 5° Loans contracted by the Agency; 6°…
The expenses of the Agence de la biomédecine include personnel, operating and investment costs and, in general, all those justified by its activity. In the context of relations with foreign organisations, the Agency is authorised to make guarantee deposits. Bank accounts for financial transactions with foreign organisations are opened with the authorisation of the Minister for the Economy.
In order to carry out its missions, the Agence de la biomédecine may in particular: 1° Acquire the necessary movable or immovable property; 2° Allocate grants, loans or advances from its own budget to public or private bodies carrying out studies, research, work or equipment contributing to the fulfilment of its missions; 3° Pay, before the service is rendered, to the benefit of foreign health establishments and by way of…
Secondary accountants may be appointed by the Managing Director after consultation with the Accounting Officer and with the approval of the Minister for the Budget.
The Agence de la biomédecine is subject to the provisions of Titles I and III of Decree 2012-1246 of 7 November 2012 on public budgetary and accounting management.
Revenue and imprest accounts may be set up in accordance with the provisions of Decree no. 2019-798 of 26 July 2019 on the revenue and imprest accounts of public bodies.
In application of Article L. 1418-1, the academies, learned medical or scientific societies and approved associations mentioned in Article L. 1114-1 may refer to the Agence de la biomédecine any request for advice or information on medical, scientific or ethical issues falling within the Agency’s areas of competence.
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Resources
is a Registered Trademark of
PETROFF LAW FIRM (SELARL LEGASTRAT)
182, rue de Rivoli
75001, Paris France
RCS Paris n°814433470
Paris Bar Registration n° (Toque) C2396
Useful links
Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.
All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.
